cbio: the cashflow

MyFinsight

For the quarter ending 2025-09-30.

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Cash Flow	2025-09-30	2025-06-30
Repurchase of equity awards	-177	-177
Net cash provided by financing activities	144,124	145,378
Net increase in cash, cash equivalents, and restricted cash	98,606	117,985
Cash and cash equivalents at beginning of period	34,766	-
Cash and cash equivalents at end of period	133,372	-

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

For the quarter ending 2025-09-30.

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Cash Flow	2025-09-30	2025-06-30
Repurchase of equity awards	-177	-177
Net cash provided by financing activities	144,124	145,378
Net increase in cash, cash equivalents, and restricted cash	98,606	117,985
Cash and cash equivalents at beginning of period	34,766	-
Cash and cash equivalents at end of period	133,372	-

Unit: Thousand (K) dollars (except for numbers of shares and EPS)